La catena delle opzioni mostra i dati chiave delle opzioni azionarie di CBIZ a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per CBIZ..

CBIZ (NYSE:CBZ) Azioni, Catena delle Opzioni

CBIZ

CBIZ Inc through its subsidiaries provides professional business services. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Agribusiness, Agribusiness, SAAS, Construction, Health Care, Oil and Gas, Real Estate, Retail, Financial Institutions, and Government among others. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.

CBIZ Inc

WIIM

ALIT

BBSI

CRAI

ELWS

EXPO

HSII

HURN

INOD

KELYA

PAYC

PAYX

PCTY

TNET

Shares of professional service companies are trading higher after Donald Trump won the 2024 presidential election.

CBIZ shares are trading higher following a Q3 EPS beat.

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) rose sharply during Tuesday's session after reporting better-than-expected third-quarter financial results and issued better-than-expected <a href="https://www.benzinga.com/quote/GLW/earnings">fourth-quarter outlook</a>.
Corning reported quarterly earnings of 54 cents per share which beat the analyst consensus estimate of 52 cents per share. The company reported quarterly sales of $3.73 billion which beat the analyst consensus estimate of $3.72 billion.
Corning shares jumped 7% to $50.12 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares jumped 39% to $77.96 after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) shares gained 25.3% to $21.35 after the company reported better-than-expected second-quarter financial results.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) gained 18% to $1.25.</li>
<li>Lithium Americas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) climbed 15.7% to $4.79. Lithium Americas closed $2.26 billion U.S. DOE ATVM loan.</li>
<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) gained 15.5% to $19.48 after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance..</li>
<li>Inari Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) gained 15.1% to $49.00 after the company reported better-than-expected third-quarter sales results and raised its FY24 revenue guidance above estimates. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $50 to $5.</li>
<li>Shutterstock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSTK#NYSE">SSTK</a>) gained 11.7% to $32.98 after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. Also, the company announced it will integrate its GIPHY API into TikTok&#8217;s messaging platform.</li>
<li>IPG Photonics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPGP#NASDAQ">IPGP</a>) gained 9.3% to $86.61 following upbeat quarterly earnings.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) gained 8.7% to $48.74 following third-quarter results.</li>
<li>Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) rose 8.4% to $71.21 after the company reported better-than-expected third-quarter revenue results and raised its FY24 net product revenue guidance.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) gained 8.3% to $16.03 after the company reported better-than-expected third-quarter financial results and raised the lower end of its FY24 net sales guidance range.</li>
<li>CBIZ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) rose 7.5% to $71.88 following upbeat quarterly earnings.</li>
<li>Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) rose 7% to $43.42.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41598309/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

News

Intraday Update

Markets

Movers

Trading Ideas

HAYW

INCY

IPGP

NARI

OPRA

RBRK

RMBS

SSTK

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) affirms FY2024 Adj EPS guidance from $2.64-2.69 to $2.64-2.69 vs $2.64 analyst estimate. Affirms FY2024 sales outlook from $1.70 billion-1.73 billion to $1.70 billion-1.73 billion vs $2.13 billion estimate.

Guidance

CBIZ Affirms FY2024 Adj EPS Guidance to $2.64-2.69 vs $2.64 Est; Total revenue to grow within a range of 7% to 9% over the prior year.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.76 by 10.53 percent. The company reported quarterly sales of $438.884 million which missed the analyst consensus estimate of $441.695 million by 0.64 percent. This is a 6.90 percent increase over sales of $410.539 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

CBIZ Q3 2024 Adj. EPS $0.84 Beats $0.76 Estimate, Sales $438.884M Miss $441.695M Estimate

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement.
Analysts estimate that CBIZ will report an earnings per share (EPS) of $0.76. 
The announcement from CBIZ is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.18, which was followed by a 5.26% increase in the share price the next day.
Here's a look at CBIZ's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.68</td>
<td>1.50</td>
<td>-0.28</td>
<td>0.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.50</td>
<td>1.54</td>
<td>-0.26</td>
<td>0.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>-4.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730127787_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of CBIZ were trading at $66.39 as of October 25. Over the last 52-week period, shares are up 28.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about CBIZ</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on CBIZ.
The consensus rating for CBIZ is Buy, derived from 1 analyst ratings. An average one-year price target of $86.0 implies a potential 29.54% upside.
<h3>Peer Ratings Overview</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of ICF International, Amentum Holdings and Clarivate, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>ICF International is maintaining an Outperform status according to analysts, with an average 1-year price target of $174.0, indicating a potential 162.09% upside.</li>
<li>The consensus outlook from analysts is an Buy trajectory for Amentum Holdings, with an average 1-year price target of $31.0, indicating a potential 53.31% downside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Clarivate, with an average 1-year price target of $6.0, implying a potential 90.96% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for ICF International, Amentum Holdings and Clarivate are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBIZ</td>
<td>Buy</td>
<td>5.40%</td>
<td>$53.64M</td>
<td>2.25%</td>
</tr>
<tr>
<td>ICF International</td>
<td>Outperform</td>
<td>2.39%</td>
<td>$182.70M</td>
<td>2.75%</td>
</tr>
<tr>
<td>Amentum Holdings</td>
<td>Buy</td>
<td>-3.07%</td>
<td>$201M</td>
<td>1.84%</td>
</tr>
<tr>
<td>Clarivate</td>
<td>Neutral</td>
<td>-2.77%</td>
<td>$436.70M</td>
<td>-6.27%</td>
</tr>
</tbody>
</table>

Key Takeaway:
CBIZ ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Unveiling the Story Behind CBIZ</h3>
CBIZ Inc through its subsidiaries provides professional business services. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Agribusiness, Agribusiness, SAAS, Construction, Health Care, Oil and Gas, Real Estate, Retail, Financial Institutions, and Government among others. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
<h3>Breaking Down CBIZ's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, CBIZ showcased positive performance, achieving a revenue growth rate of 5.4% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: CBIZ's net margin excels beyond industry benchmarks, reaching 4.71%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): CBIZ's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.25%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CBIZ's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.91%, the company may face hurdles in achieving optimal financial returns.
Debt Management: CBIZ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.69.
<a href="https://www.benzinga.com/quote/CBZ/earnings">To track all earnings releases for CBIZ visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of CBIZ's Earnings Potential

Sidoti &amp; Co. analyst Marc Riddick upgrades CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) from Neutral to Buy and announces $86 price target.

Upgrades

Price Target

Analyst Ratings

Sidoti & Co. Upgrades CBIZ to Buy, Announces $86 Price Target

CBIZ shares are trading lower after the company reported worse-than-expected Q2 financial results. Additionally, the company announced it entered into an agreement to acquire the Non-attest business of Marcum in a cash and stock transaction value at $2.3 billion.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.68 by 26.47 percent. This is a 9.09 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $420.01 million which missed the analyst consensus estimate of $430.38 million by 2.41 percent. This is a 5.40 percent increase over sales of $398.50 million the same period last year.

CBIZ Q2 Adj. EPS $0.50 Misses $0.68 Estimate, Sales $420.01M Miss $430.38M Estimate

CBIZ Entered Into A Definitive Agreement To Acquire The Non-attest Business Of Marcum In A Cash-and-stock Transaction Is Valued At Approximately $2.3B

CBIZ Sees FY24 Revenue Growth Of 7% - 9%; Adj EPS Of $2.70 - $2.75 Vs. $2.72 Est.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of $1.50 by 2.67 percent. This is a 5.48 percent increase over earnings of $1.46 per share from the same period last year. The company reported quarterly sales of $494.30 million which beat the analyst consensus estimate of $490.88 million by 0.70 percent. This is a 8.73 percent increase over sales of $454.61 million the same period last year.

CBIZ Q1 Adj $1.54 Beats $1.50 Estimate, Sales $494.30M Beat $490.88M Estimate

CBIZ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) ("the Company"), a leading provider of financial, insurance and advisory services, announced today it has acquired technology solutions provider, CompuData, Inc. (CompuData), of Philadelphia, PA, effective March 1, 2024.
Founded in 1971, CompuData is a premier technology solutions provider for small and midsize organizations. They provide cloud computing, accounting ERP software, managed IT and security to clients with the tools to scale, protect, and streamline their organizations. CompuData is a Sage Diamond Partner and has Microsoft Partner designation in both Azure Cloud and Modern Work. The firm has 60 employees and approximately $20 million in annual revenue.
Jerry Grisko, President and CEO of CBIZ, said, "We have experienced an increasingly high demand across the country for precisely the suite of services that CompuData has built an impressive reputation providing. In the CompuData team, we have found a partner that is equally invested in and dedicated to its clients' success by offering essential solutions that they rely on. For these reasons and more, we are thrilled to welcome CompuData to CBIZ."
Angela Nadeau, President and CEO of CompuData, stated, "Our entire team is very excited to join forces with such a strong and nationally recognized partner such as CBIZ. Our industry verticals, including financial services, construction, manufacturing, distribution, and technology, align extremely well. We see great opportunity and expect our partnership to be mutually beneficial to our valued employees and clients."

CBIZ Acquires Compudata, Inc.; Financial Terms Of Transaction Not Disclosed

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. The company reported quarterly sales of $327.55 million which beat the analyst consensus estimate of $309.02 million by 5.99 percent. This is a 11.02 percent increase over sales of $295.04 million the same period last year.

CBIZ Q4 2023 Adj EPS $(0.26) Beats $(0.27) Estimate, Sales $327.55M Beat $309.02M Estimate

AGIO

ALKS

ALLT

ALNY

AMAT

AORT

APPN

ARCH

ATRC

AUPH

BJRI

BLZE

BPMC

CBRE

CGNX

CLBT

CMBM

COHU

COIN

CORT

CRBG

CROX

CWST

DASH

DKNG

DNOW

EDRY

ELME

EPAM

GLOB

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HOUS

HTGC

IDCC

IRDM

IREN

IRWD

ITGR

JMIA

KELYB

KNSL

LBTYA

LECO

Laboratory Corporation Of America Holdings

MERC

MTRN

MYTE

NSIT

NVMI

OPEN

ORAN

OTLY

PACB

PCOR

PDFS

PENN

PRAA

PRTA

RARE

RELX

ROKU

RPRX

Earnings Scheduled For February 15, 2024

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) is set to give its latest quarterly earnings report on Thursday, 2024-02-15. Here's what investors need to know before the announcement.
Analysts estimate that CBIZ will report an earnings per share (EPS) of $-0.28. 
CBIZ bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.07, which was followed by a 1.42% drop in the share price the next day.
Here's a look at CBIZ's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.59</td>
<td>0.65</td>
<td>1.25</td>
<td>-0.21</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.66</td>
<td>0.55</td>
<td>1.46</td>
<td>-0.21</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.42%</td>
<td>1.71%</td>
<td>-0.06%</td>
<td>5.96%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707922907_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of CBIZ were trading at $63.35 as of February 13. Over the last 52-week period, shares are up 35.98%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CBZ/earnings">To track all earnings releases for CBIZ visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: CBIZ

Sidoti &amp; Co. analyst Marc Riddick downgrades CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) from Buy to Neutral and announces $63 price target.

Downgrades

Sidoti & Co. Downgrades CBIZ to Neutral, Announces $63 Price Target

Sidoti &amp; Co. analyst Marc Riddick upgrades CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) from Neutral to Buy and announces $63 price target.

Sidoti & Co. Upgrades CBIZ to Buy, Announces $63 Price Target

CBIZ Sees FY23 Adj EPS Up 11%-13% To $2.36-$2.41 Vs $2.36 Est.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.59 by 11.86 percent. This is a 29.41 percent increase over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $410.54 million which beat the analyst consensus estimate of $395.53 million by 3.79 percent. This is a 13.01 percent increase over sales of $363.26 million the same period last year.

CBIZ Q3 Adj EPS $0.66 Beats $0.59 Estimate, Sales $410.54M Beat $395.53M Estimate

Tax firm Andersen Global evaluating IPO - WSJ

Warning: CBZ is at high risk of performing badly

Backs FY24 revenue growth view 7%-9%. Sees FY24 effective tax rate 28%. The company said, "With an expected close in the fourth quarter of 2024, cu...

CBIZ backs FY24 adjusted EPS view $2.64-$2.69, consensus $2.64

Reports Q3 revenue $438.88M, consensus $441.69M. Jerry Grisko, CBIZ (CBZ) president and CEO, said, "Adjusted earnings per share were up by over 27%...

CBIZ reports Q3 adjusted EPS 84c, consensus 76c

CBIZ Non-GAAP EPS of $0.84 beats by $0.08, revenue of $438.88M misses by $2.81M

CBIZ, Inc. (CBZ) Q3 2024 Earnings Call Transcript

CBIZ, Inc. 2024 Q3 - Results - Earnings Call Presentation

CBIZ Inc ( ($CBZ) ) has realeased its Q3 earnings. Here is a breakdown of the information CBIZ Inc presented to its investors. CBIZ Inc., a major p...

CBIZ Inc. Reports Strong Q3 2024 Results

CBIZ (CBZ) announced it has completed the acquisition of the non-attest business of Marcum, with expected combined annualized revenue of approximat...

CBIZ completes acquisition of Marcum

CBIZ ( ($CBZ) ) has issued an update. CBIZ, Inc. has completed the acquisition of Marcum's non-attest business, enhancing its position as a leading...

CBIZ Expands with Major Acquisition of Marcum's Business

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IROH, CPTN, GVP, CBZ on Behalf of Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBZ, PWUP, ESGR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTM, GVP, CBZ on Behalf of Shareholders

Penny Stocks

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Looming Votes of CBZ, GVP and AFBI

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, CBZ, RCM, OB on Behalf of Shareholders

Insurance

CBIZ TO ANNOUNCE THIRD-QUARTER RESULTS ON OCTOBER 29, 2024

In Unsettled Economy, Small and Mid-Sized Businesses Struggle with Staffing as Inflation Pressures and Rising Health Care Costs Persist

Comments

CBIZ

CBIZ (CBZ) Opzioni

CBIZ (NYSE:CBZ) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO